Antibiotic therapy - Biotech, Pharma and Life Science Channel

07:38 EDT 2nd September 2014 | BioPortfolio

PubMed Articles [10170 Associated PubMed Articles listed on BioPortfolio]

BiDil in the Clinic: An Interdisciplinary Investigation of Physicians' Prescription Patterns of a Race-Based Therapy.

The African American Heart Failure Trial (A-HeFT) and the FDA approval of BiDil for race-specific prescription have stirred the debate about the scientific and medical status of race. Yet there is no ...

Porous silicon-cyclodextrin based polymer composites for drug delivery applications.

One of the main applications of porous silicon (PSi) in biomedicine is drug release, either as a single material or as a part of a composite. PSi composites are attractive candidates for drug delivery...

Characterization and cytocompatibility of an antibiotic/chitosan/cyclodextrins nanocoating on titanium implants.

A novel ciprofloxacin loaded chitosan nanoparticle-based coating onto titanium substrates has been developed and characterized to obtain an orthopaedic implant surface able to in situ release the anti...

Construction of serum resistant micelles based on heparosan for targeted cancer therapy.

A novel micelle based on heparosan and deoxycholic acid (DOCA) conjugate (HD) as drug carrier was reported here. As the surface was negatively charged, this micelle could resist serum adsorption, show...

Pure ZnO and composite ZnO/TiO2 catalyst plates: A comparative study for the degradation of azo dye, pesticide and antibiotic in aqueous solutions.

Photocatalytic degradations of azo dye (RR 180), pesticide (2,4-D) and antibiotic (enrofloxacin) in aqueous solutions were performed and compared by using pure ZnO and ZnO/TiO2 composite (at 1:1 ZnO t...

Autologous Bone Marrow Transplantation for the Treatment of Multiple Sclerosis.

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and represents one of the leading causes of neurologic disability in young adults. Current treatments for MS hav...

A standalone Internet cognitive behavior therapy treatment for social anxiety in adults who stutter: CBTpsych.

Social anxiety is common for those who stutter and efficacious cognitive behavior therapy (CBT) for them appears viable. However, there are difficulties with provision of CBT services for anxiety amon...

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation.

The Seattle Heart Failure Model (SHFM) predicts survival in heart failure but may underestimate risk in severe heart failure, and the performance has not been evaluated explicitly in patients with car...

Radiation-induced Effects to Nontarget Abdominal and Pelvic Viscera.

Radiation injuries often occur during or after radiation therapy in the abdomen or pelvis. Although any organ in the abdomen or pelvis may be exposed to and injured by radiation therapy directed to a ...

Imaging of Chemotherapy-related Iatrogenic Abdominal and Pelvic Conditions.

Oncologic therapy is constantly evolving to improve patient outcomes, especially with regard to chemotherapy. The use of combination therapies and development and implementation of molecular targeted ...

News Articles [5877 Associated News Articles listed on BioPortfolio]

Ophthotech Corporation to Present at the 2014 Morgan Stanley Global Healthcare Conference

- Webcast Available Through Ophthotech Website - Ophthotech Corporation (NASDAQ:OPHT) announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Bo...

Physical Therapists in Houston Learn Pain Relief Techniques

As part of their continuing goal to help physical therapists help others, Hands-On Seminars will provide health care professionals in the Houston and Beaumont areas with intensive training in manual t...

Only a tenth of pregnant smokers are prescribed nicotine replacement therapy

Only a tenth of pregnant women who smoke are prescribed nicotine replacement therapy (NRT) and many opportunities for smoking cessation are lost, says a study published in the British Journal of... ...

Neuravi Introduces Collaborative Clot Research Initiative at ESMINT Conference in September

Advancing Stroke Therapy through The Science of Clot Neuravi, a developer of innovative stroke therapy, announced today that it will introduce the Neuravi Thromboembolic Initi...

ReNeuron says dosing of patients in two clinical trials has started

ReNeuron (LON:RENE) said the first patients have been dosed in both of the ReN001 and ReN009 trials flagged in its June results statement. The ReN001 cell therapy candidate for stroke disability is un...

BRIEF-Elekta gets Japan clearance for new linear accelerator

Sept 2 (Reuters) - Elekta : * Elekta's versa hd radiation therapy system now available for treatment of

[Articles] Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

In a patient population with minimum exclusion criteria and high adherence to dual antiplatelet therapy, biodegradable polymer sirolimus-eluting stents were non-inferior to durable polymer everolimus-...

NormoCort Could Become Leading Cushing’s Syndrome Drug, Says GlobalData

Cortendo’s NormoCort has the potential to become the front-line medical therapy for cushing’s syndrome (CS), but only if its commercial strategy adapts to a growing market

Cellceutix Appoints Dr. Barry Schechter to Board of Directors as Company Focuses on Meeting Requirements for Stock Exchange Uplisting

BEVERLY, MA -- (Marketwired) -- 09/02/14 -- Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, ...

uniQure Announces Results for the Second Quarter and First Half of 2014 and Provides Update on Gene Therapy Programs

AMSTERDAM, the Netherlands, Sept. 2, 2014 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced results for the second quarter of 2014 and an update on multi...

Events [0 Results]

None

Companies [263 Associated Companies listed on BioPortfolio]

TherapeuticsMD Inc.

TherapeuticsMD Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. TherapeuticsMD is developing advanced hormone the...

BioSensics

BioSensics is a research and product development company specializing in wearable sensors for healthcare, offering innovative monitoring solutions for telehealth, aging-in-place, ...

Transplant Genomics Inc.

Transplant Genomics is a molecular diagnostics company committed to improving organ transplant outcomes. Working with the transplant community, TGI will bring vital advances in di...

Devon Medical Products, Inc.

Devon Medical Products, Inc. (www.devonmedicalproducts.com) is an ISO 13485 medical device manufacturer, designer, and distributor. Since 2005, we have developed innovative and hi...

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). Voyager is committed to...

US Oncology Network

Optim Oncology is dedicated to providing patient-centered, integrated cancer care in convenient locations close to patients’ homes. Medical and radiation specialists work tog...

Phoenix House Foundation

As a leading nonprofit provider of substance abuse treatment and prevention services since 1967, Phoenix House helps more than 7,000 men, women and teens each day as they overcome...

Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics is a subsidiary of BioTime, Inc., whose mission is to acquire and develop best in class cell therapy product candidates. Our first acquisition was the ste...

Aclaris Therapeutics Inc.

Aclaris Therapeutics, Inc., started by the founders of Vicept Therapeutics, is a privately held specialty pharmaceutical dermatology company focused on the development of novel de...

The Emily Program

The Emily Program was founded in 1993 by Dirk Miller, PhD, LP, after his sister Emily recovered from an eating disorder. To date, The Emily Program has provided more than 4,500 cl...

Clinical Trials [1025 Associated Clinical Trials listed on BioPortfolio]

Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression

This study will compare four types of electroconvulsive therapy to determine if they differ in their effects on mood, thinking, brain activity, and biochemistry in people with major depres...

Peri-operative Cefazolin Prophylaxis at Time of Cesarean Delivery in the Obese Gravida

Obesity has become an increasingly prevalent public health problem in the United States, reaching epidemic proportions. According to 2009 CDC epidemiologic data on obesity in the United St...

Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

Approximately a fourth of children with seizures do not respond adequately to available therapy. Ketogenic therapy has a long history as treatment for intractable epilepsy, but there is n...

Impact of Infectious Diseases Specialists on the Appropriateness of Antimicrobial Therapy in Surgical and Medical Wards

CONTEXT: Antibiotics are frequently used in hospital but the appropriateness of prescriptions ranged between 25-50%. The intervention of infectious disease specialists (IDS) could improve ...

R-wave Optimisation in Cardiac Resynchronisation Therapy Study

The aim of this study is to investigate whether the use of a simple feature on the 12 lead electrocardiogram (ECG) to optimise pacemaker device programming can have clinically relevant ben...

Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression

Psychological therapies for depression have demonstrated efficacy, but outcomes are still unsatisfactory, especially in cases with high comorbidity. Depression and anxiety co-occur in up t...

Study of Alirocumab (REGN727/ SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)

This is a randomized, double-blind, placebo-controlled, parallel-group, multi-national study alirocumab (REGN727/ SAR236553) in patients with Heterozygous Familial Hypercholesterolemia (he...

Music Therapy in Methodist Homes: a Study Investigating the Impact of a Music Therapy Programme

The study is a cluster randomised control trial, which aims to investigate the effectiveness of music therapy in minimising Behavioural and Psychological Symptoms of Dementia (BPSD) in old...

Patient Education in Rheumatoid Arthritis and Osteoarthritis

This project will evaluate the effectiveness and general usefulness of two arthritis patient education programs. The first, the Arthritis Self-Management Program, is a 6-week, community-ba...

Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and Zidovudine

To determine if the pharmacokinetics of high doses of zidovudine (AZT) (that is, how fast AZT reaches the blood, what concentration of AZT is attained in the blood, and how long AZT remain...

Medical and Biotech [MESH] Definitions

A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.

Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.

The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.

A common inhabitant of the colon flora in human infants and sometimes in adults. It produces a toxin that causes pseudomembranous enterocolitis (ENTEROCOLITIS, PSEUDOMEMBRANOUS) in patients receiving antibiotic therapy.

A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient's condition. Salvage therapy is most often used for neoplastic diseases.

Search BioPortfolio:
Advertisement
Advertisement
review and buy Antibiotic therapy market research data and corporate reports here

Channels Quicklinks